Lantheus Holdings Faces Class Action Lawsuit
Pomerantz LLP has announced that a class action lawsuit has been filed against Lantheus Holdings, Inc. (NASDAQ: LNTH). This action targets investors who may have suffered losses and encourages those impacted to seek assistance.
The Nature of the Class Action
The lawsuit challenges allegations of securities fraud involving Lantheus and certain company officers and directors. The firm representing the class action believes that these individuals engaged in unlawful business practices, causing investors significant financial harm.
Important Deadlines for Investors
Investors who acquired Lantheus securities during the Class Period have until November 10, 2025, to request court appointment as Lead Plaintiff. This is a vital step for those wanting to take a stand in this legal matter.
Recent Financial Performance
On May 7, 2025, Lantheus released their financial results for the first quarter, which revealed a decline in performance that didn't meet market expectations. The company reported a decrease in sales for their radiopharmaceutical oncology product, Pylarify, citing a "temporal competitive disruption" as a key factor in this decline.
Consequently, on that day, Lantheus's stock experienced a notable drop of $24.35 per share, marking a 23.23% decline as it closed at $80.49 per share.
Implications of Second Quarter Results
Further compounding investor concerns, Lantheus announced additional disappointing results for the second quarter on August 6, 2025. They reported that earnings-per-share and revenue figures fell short of investor expectations, leading to a revised lowering of growth projections for Pylarify.
With sales dropping year-over-year by 8.3%, Lantheus's stock witnessed another significant decrease of $20.76 per share, amounting to a 28.58% decline, closing at $51.87 per share that day.
Pomerantz LLP’s Role
Pomerantz LLP, a firm renowned for its expertise in corporate, securities, and antitrust class litigation, is committed to upholding the rights of investors affected by corporate misconduct. Founded by the late Abraham L. Pomerantz, the firm has a long-standing reputation for securing substantial damages on behalf of those wronged in financial markets.
For those with inquiries regarding the lawsuit, Danielle Peyton at Pomerantz LLP is available at 646-581-9980, or you may reach out via email to dpeyton@pomlaw.com.
Frequently Asked Questions
What is the class action lawsuit about?
The lawsuit involves allegations of securities fraud against Lantheus Holdings and certain officers, alleging unlawful business practices.
Who can be a Lead Plaintiff in the class action?
Investors who purchased Lantheus securities during the Class Period can apply to be appointed as Lead Plaintiff until November 10, 2025.
How did Lantheus's financial performance impact its stock?
Recent disappointing financial results led to significant drops in Lantheus's stock price, prompting concerns among investors.
What has Pomerantz LLP achieved in similar cases?
Pomerantz LLP has a history of obtaining favorable damages awards for investors in cases involving corporate misconduct and securities fraud.
Who can I contact for more information about the lawsuit?
Contact Danielle Peyton at Pomerantz LLP directly at 646-581-9980 for further assistance regarding the class action lawsuit.
